论文部分内容阅读
目的:探讨血清CA125监测对卵巢癌患者的临床应用价值。方法:运用电化学发光免疫测定法对卵巢癌患者、卵巢良性肿瘤患者血清CA125进行测定,另选取健康体检人群作为对照。结果:卵巢癌患者、卵巢良性肿瘤、正常对照组差异均有显著性(P<0.01)。结论:测定血清CA125对卵巢癌的诊断、鉴别诊断有重要价值。
Objective: To investigate the clinical value of serum CA125 monitoring in patients with ovarian cancer. Methods: The levels of serum CA125 in patients with ovarian cancer and benign ovarian tumors were determined by electrochemiluminescence immunoassay. The healthy control subjects were selected as the control group. Results: There were significant differences between ovarian cancer patients, benign ovarian tumors and normal controls (P <0.01). Conclusion: The determination of serum CA125 in ovarian cancer diagnosis, differential diagnosis of great value.